Atlas Venture Associates Opportunity I, L.P.'s Net Worth

$474 Million

Estimate Recalculated Feb 21, 2024 06:49PM EST

Who is Atlas Venture Associates Opportunity I, L.P.?

Atlas Venture Associates Opportunity I, L.P. has an estimated net worth of $474 Million. This is based on reported shares across multiple companies, which include Vigil Neuroscience, Inc., Day One Biopharmaceuticals, Inc., Dyne Therapeutics, Inc., Generation Bio Co., Akero Therapeutics, Inc., Replimune Group, Inc., Ikena Oncology, Inc., Kymera Therapeutics, Inc., Magenta Therapeutics, Inc., Disc Medicine, Inc., Xilio Therapeutics, Inc., AVROBIO, Inc., and Third Harmonic Bio, Inc..

SEC CIK

Atlas Venture Associates Opportunity I, L.P.'s CIK is 0001780065

Past Insider Trading and Trends

2022 was Atlas Venture Associates Opportunity I, L.P.'s most active year for acquiring shares with 10 total transactions. Atlas Venture Associates Opportunity I, L.P.'s most active month to acquire stocks was the month of May. 2023 was Atlas Venture Associates Opportunity I, L.P.'s most active year for disposing of shares, totalling 31 transactions. Atlas Venture Associates Opportunity I, L.P.'s most active month to dispose stocks was the month of November. 2022 saw Atlas Venture Associates Opportunity I, L.P. paying a total of $34,090,021.70 for 16,180,239 shares, this is the most they've acquired in one year. In 2023 Atlas Venture Associates Opportunity I, L.P. cashed out on 675,637 shares for a total of $34,351,525.03, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Generation Bio Co. (GBIO) Snapshot price: $1.8602

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-85.41%
-185.08K
$25.05
-$4,635,967.02
31.62K
Scheduled
Jun 21 - Jun 23
Form 4
+387.54%
10.04M
12.63M
Jun 16
Form 3
0
0
No matching records found

Ikena Oncology, Inc. (IKNA) Snapshot price: $1.43

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+4.89%
98.72K
$15.34
$1,614,428.13
2.12M
Mar 30 - Dec 14
Form 4
+2,809.29%
4.75M
4.92M
Mar 30
Form 3
0
0
No matching records found

Kymera Therapeutics, Inc. (KYMR) Snapshot price: $34.215

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-2.11%
-126.47K
$30.22
-$3,821,738.64
5.86M
Scheduled
Jan 11 - Jan 12
Form 4
-6.00%
-382.24K
$31.36
-$11,985,953.69
5.98M
Scheduled
Dec 14 - Dec 15
Form 4
-3.34%
-220.02K
$30.01
-$6,602,952.38
6.37M
Scheduled
Nov 2 - Nov 3
Form 4
-4.20%
-288.70K
$30.26
-$8,735,143.37
6.59M
Scheduled
Oct 28 - Nov 1
Form 4
+1,104.37%
8.31M
9.06M
Aug 25
Form 3
0
0
No matching records found

Disc Medicine, Inc. (IRON) Snapshot price: $65.62

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-6.11%
-150.00K
$67.65
-$10,147,500.00
2.3M
Jan 23
Form 4
-2.19%
-50.00K
$64.00
-$3,200,000.00
2.24M
Jan 10
Form 4
-7.68%
-190.16K
$61.45
-$11,684,586.39
2.29M
Dec 12 - Dec 14
Form 4
-11.25%
-359.00K
$52.46
-$18,845,200.00
2.83M
Aug 14 - Aug 15
Form 4
+572.90%
2.72M
3.19M
Dec 29
Form 3
0
0
No matching records found

Day One Biopharmaceuticals, Inc. (DAWN) Snapshot price: $15.83

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
766.67K
$15.00
$11,500,005.00
766.67K
Jun 17
Form 4
9M
$16.00
$8,000,000.00
9M
Feb 1 - Jun 1
Form 3
0
0
No matching records found